Search results
Results from the WOW.Com Content Network
The 2015 update of guidelines of the Association of Gynecological Oncology (AGO), an autonomous community of the German Society of Gynecology and Obstetrics (DGGG) and the German Cancer Society includes TARGIT IORT during lumpectomy as a recommended option for women with a T1, Grade 1 or 2, ER positive breast cancer. [5]
Superficial X-rays are low-energy X-rays that do not penetrate very far before they are absorbed. They are produced by X-ray tubes operating at voltages in the 10–100 kV range, and therefore have peak energies in the 10–100 keV range. [1] The Maximar-100 was a widely-adopted superficial radiation therapy unit.
The Maximar-100 is a radiation therapy device that was made by General Electric to deliver superficial x-rays. Maximar 100 X-Ray Unit Superficial Therapy. The Maximar-100's x-ray source is the GE SRT-1, [1] an x-ray tube specifically designed for use in the Maximar-100. This is a fixed-anode, reflection-type x-ray tube, whose name is composed ...
Jennifer Tipsworth, 47, is a breast cancer survivor — but radiation took a toll on her body and left her in pain. Community rallies to support Brighton woman losing ribs to radiation Skip to ...
The AOL.com video experience serves up the best video content from AOL and around the web, curating informative and entertaining snackable videos.
Doctor reviewing a radiation treatment plan. In radiotherapy, radiation treatment planning (RTP) is the process in which a team consisting of radiation oncologists, radiation therapist, medical physicists and medical dosimetrists plan the appropriate external beam radiotherapy or internal brachytherapy treatment technique for a patient with cancer.
External beam radiation therapy (EBRT) is a form of radiotherapy that utilizes a high-energy collimated beam of ionizing radiation, from a source outside the body, to target and kill cancer cells. The radiotherapy beam is composed of particles, which are focussed in a particular direction of travel using collimators. [ 1 ]
Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.